Latest News and Press Releases

Dublin, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The "2024 United States Biosurgery Market Forecast (2025-2030 Outlook) - Market Opportunities Report" report has been added to ResearchAndMarkets.com's...

Corza Medical announces the appointment of Derek Chaves as its new Chief Financial Officer (CFO), effective July 8, 2024.

Corza Medical successfully closed its previously announced acquisition of the TachoSil manufacturing operations in Linz, Austria.

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies WESTWOOD, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Corza Medical...

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Surgical Adhesion Barriers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...

Burlingame, June 30, 2023 (GLOBE NEWSWIRE) -- The global biosurgery market was valued at US$ 13.89 Billion in 2021 and is forecast to reach a value of US$ 22.21 Billion by 2028 at a CAGR of 6.9%...

WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...

WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...

Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Soft Tissue Repair Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By Region; Segment Forecast, 2022-2030" report has...

Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Asia-Pacific Biosurgery Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific biosurgery market is likely to...